Get the Stockscreener App
2.815
1.23%
-0.035
After Hours:
2.78
-0.035
-1.24%
Trxade Health Inc Stock (MEDS) Forecast
The Trxade Health Inc (MEDS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.3491, representing a -16.55% decrease from the current price of $2.815. The highest analyst price target is $2.9202, and the lowest is $1.778.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MEDS Price Target
Average 1.4632
(-48.02% Downside)
Is Trxade Health Inc (MEDS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.10 | Neutral |
| STOCH(9,6) | 14.24 | Buy |
| STOCHRSI(14) | 10.67 | Buy |
| MACD(12,26) | 0.0979 | Sell |
| ADX(14) | 53.71 | Buy |
| William %R | -91.75 | Buy |
| CCI(14) | -80.66 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.1105
Sell
|
3.0776
Sell
|
| MA20 |
3.4235
Sell
|
3.0656
Sell
|
| MA50 |
2.3041
Buy
|
2.6078
Buy
|
| MA100 |
1.503
Buy
|
0.00
Buy
|
| MA200 |
0.7515
Buy
|
0.00
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, MEDS could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on MEDS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 48.1 indicates that MEDS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.24 indicates that MEDS is oversold. This indicates that MEDS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.67 indicates that MEDS is oversold. This suggests that MEDS price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 53.71 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -80.66 indicates that MEDS is still oversold but not to an extreme extent.
Long-term MEDS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Trxade Health Inc financial reports and earnings history, Trxade Health Inc (MEDS) stock could reach $9.223 by 2030, $2.0594 by 2040 and $8.2272 by 2050. See the projected annual prices until 2050 of the Trxade Health Inc stock below:
- Trxade Health Inc (MEDS) is expected to reach an average price of $2.767 in 2035, with a high prediction of $2.707 and a low estimate of $2.7232. This indicates an $-1.71% rise from the last recorded price of $2.815.
- Trxade Health Inc (MEDS) stock is projected to chart a bullish course in 2040, with an average price target of $0.5085, representing an $-81.94% surge from its current level. The forecast ranges from a conservative $0.3153 to a sky-high $2.0594.
- Our analysts predict Trxade Health Inc (MEDS) to jump 131.30% by 2045, soaring from $5.9836 to an average price of $6.511, potentially reaching $6.141. While $5.9836 is the low estimate, the potential upside is significant.
- Trxade Health Inc (MEDS) stock is expected to climb by 2050, reaching an average of $8.2482, a $193.01% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.2272 and $8.231, respectively, highlighting the market's uncertainty.
Trxade Health Inc Stock (MEDS) Year by Year Forecast
Trxade Health Inc Stock (MEDS) Price Forecast for 2026
The predicted value for Trxade Health Inc (MEDS) in 2026 is set at an average of $6.5663. Estimates vary from a peak of $12.31 to a trough of $0.8225, indicating an +133.26% surge from the present price of $2.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.8806 | $1.778 | $2.9202 | -33.19% |
| December, 2026 | $1.2311 | $1.1111 | $1.9233 | -56.27% |
Trxade Health Inc Stock (MEDS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Trxade Health Inc (MEDS) is $1.0495, with a high forecast of $2.0928 and a low forecast of $0.00625. This indicates an -62.72% decrease from the last price of $2.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.5315 | $0.5315 | $1.3137 | -81.12% |
| February, 2027 | $0.4119 | $0.2641 | $0.7493 | -85.37% |
| March, 2027 | $0.475 | $0.2471 | $0.8145 | -83.13% |
| April, 2027 | $1.0954 | $0.3776 | $2.0928 | -61.09% |
| May, 2027 | $0.2084 | $0.1884 | $1.3506 | -92.60% |
| June, 2027 | $0.1973 | $0.00625 | $0.5463 | -92.99% |
| July, 2027 | $0.1093 | $0.0433 | $0.3541 | -96.12% |
| August, 2027 | $0.3423 | $0.1169 | $0.4497 | -87.84% |
| September, 2027 | $0.0472 | $0.0572 | $0.4649 | -98.32% |
| October, 2027 | $0.0532 | $0.1095 | $0.2132 | -98.11% |
| November, 2027 | $0.3863 | $0.2242 | $0.1984 | -86.28% |
| December, 2027 | $0.4434 | $0.4041 | $0.3834 | -84.25% |
Trxade Health Inc Stock (MEDS) Price Forecast for 2028
In 2028, Trxade Health Inc (MEDS) is projected to reach an average price of $9.5483, with a high projection of $18.52 and a low estimate of $0.5807. This indicates an +239.19% rise from the last price of $2.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.7408 | $0.5807 | $0.6814 | -73.68% |
| February, 2028 | $0.8573 | $0.8142 | $0.7685 | -69.55% |
| March, 2028 | $0.8015 | $0.8795 | $0.8173 | -71.53% |
| April, 2028 | $0.8889 | $0.8392 | $0.7823 | -68.42% |
| May, 2028 | $0.866 | $0.8388 | $0.8172 | -69.24% |
| June, 2028 | $0.9184 | $0.8907 | $0.9182 | -67.38% |
| July, 2028 | $0.8924 | $0.8517 | $0.873 | -68.30% |
| August, 2028 | $0.8878 | $0.8902 | $0.9092 | -68.46% |
| September, 2028 | $12.01 | $0.9095 | $18.52 | +326.58% |
| October, 2028 | $8.8214 | $5.0664 | $12.27 | +213.37% |
| November, 2028 | $6.4818 | $5.1418 | $9.334 | +130.26% |
| December, 2028 | $5.5822 | $5.3122 | $13.21 | +98.30% |
Trxade Health Inc Stock (MEDS) Price Forecast for 2029
The 2029 price forecast for Trxade Health Inc Stock (MEDS) is $23.05 on average, with a high prediction of $43.49 and a low estimate of $2.6022. This represents an +718.65% increase from the previous price of $2.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.0253 | $4.3865 | $6.7626 | +78.52% |
| February, 2029 | $4.8757 | $3.9357 | $5.1005 | +73.20% |
| March, 2029 | $5.0711 | $4.1783 | $5.4011 | +80.15% |
| April, 2029 | $3.7741 | $3.3091 | $5.0487 | +34.07% |
| May, 2029 | $3.1896 | $2.7144 | $4.5995 | +13.31% |
| June, 2029 | $8.44 | $2.6022 | $12.82 | +199.82% |
| July, 2029 | $9.173 | $6.7152 | $43.49 | +225.86% |
| August, 2029 | $5.2535 | $4.7636 | $9.4855 | +86.62% |
| September, 2029 | $4.7939 | $4.2513 | $5.8261 | +70.30% |
| October, 2029 | $8.0669 | $4.5165 | $10.24 | +186.57% |
| November, 2029 | $13.72 | $7.2295 | $22.75 | +387.30% |
| December, 2029 | $7.3604 | $5.2804 | $13.98 | +161.47% |
Trxade Health Inc Stock (MEDS) Price Forecast for 2030
Trxade Health Inc Stock (MEDS) is expected to reach an average price of $5.6801 in 2030, with a high forecast of $11.34 and a low forecast of $0.0207. This signifies an +101.78% surge from the last price of $2.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.3308 | $5.4282 | $9.223 | +124.90% |
| February, 2030 | $1.0013 | $0.9113 | $6.7034 | -64.43% |
| March, 2030 | $0.0153 | $0.0207 | $1.1039 | -99.46% |
| April, 2030 | $2.2047 | $0.0607 | $11.34 | -21.68% |
| May, 2030 | $1.37 | $1.36 | $3.3873 | -51.33% |
| June, 2030 | $0.8109 | $0.7609 | $1.5552 | -71.20% |
| July, 2030 | $0.00693 | $0.1523 | $0.8625 | -99.75% |
| August, 2030 | $0.5922 | $0.3079 | $0.3222 | -78.96% |
| September, 2030 | $0.9861 | $0.877 | $0.8118 | -64.97% |
| October, 2030 | $0.9353 | $0.9909 | $0.9405 | -66.77% |
| November, 2030 | $0.0156 | $0.5544 | $0.7156 | -99.45% |
| December, 2030 | $1.0284 | $0.2898 | $0.7184 | -63.47% |
4.82%
4.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):